Xin Lang Cai Jing·2026-01-23 10:55Core Viewpoint - China Life Insurance Company plans to establish a private equity fund in partnership with Shanghai Pudong Leading Area Investment Center and others, focusing on investment in technology innovation companies in the Yangtze River Delta region, particularly in artificial intelligence, integrated circuits, and biomedicine [1][5]. Group 1: Investment Details - The total committed capital for the partnership is RMB 50.5 billion, with China Life contributing RMB 40 billion [1][5]. - The fund will be managed by Guoshou Capital Investment Co., Ltd., which constitutes a related party transaction [1][5]. Group 2: Investment Focus - The partnership aims to invest in growth-stage technology innovation enterprises within three leading industries: artificial intelligence, integrated circuits, and biomedicine [1][5][12]. - The investment strategy aligns with national policy directions and aims to enhance investment returns from insurance funds [12]. Group 3: Approval Process - The investment proposal was approved by the company's board of directors and relevant committees, with no objections from non-related directors [13]. - The transaction does not require shareholder meeting approval as it does not meet the threshold for significant asset restructuring [14][15]. Group 4: Historical Context - In the past 12 months, the cumulative amount of related party transactions between the company and its group has exceeded RMB 30 million but does not account for more than 5% of the company's latest audited net assets [16].